1152922

Acella Pharmaceuticals, LLC — FEI 3006691461

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 17, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Alpharetta, GA (United States)

Citations

IDCFRDescription
104921 CFR 211.22(a)Approve or reject components, products
111121 CFR 211.25(a)Training , Education , Experience overall
135821 CFR 211.100(b)SOPs not followed / documented
202721 CFR 211.192Investigations of discrepancies, failures
438921 CFR 211.198(a)Procedures to be written and followed